| 臺大學術典藏 |
2022-09-14T01:29:27Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; CHIEN-HUNG CHEN; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group |
| 臺大學術典藏 |
2022-08-19T00:20:39Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Ni Y.-H.; Lin C.-L.; Hsu Y.-C.; Hsu C.-W.; Wu C.-Y.; Wu J.-C.; Cheng J.C.-H.; Leung S.W.; Chen S.-W.; Hsu H.-C.; Hong J.-H.; Wang P.-M.; Wang P.-M.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; CHIUN HSU; Chao Y.; Chen L.-T.; Lee P.-H.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Hung C.-F.; Huang S.-F.; Yang S.-S.; Chen R.-C.; Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N. |
| 臺大學術典藏 |
2022-08-19T00:20:34Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS�VESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Douillard J.-Y.; Yoshino T.; Yen Y.; Hsu C.-H.; Tabernero J.; Shen Y.-C.; CHIUN HSU; Chen S.-C.; Huang Y.-H.; Yen C.-J.; Qin S.; Bhattacharyya G.S.; Ikeda M.; Lim H.-Y.; Ho G.F.; Choo S.P.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Pentheroudakis G.; Cheng A.-L.; Chen L.-T.; Martinelli E. |
| 臺大學術典藏 |
2022-05-05T05:16:08Z |
Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: Long-term predictors from a community-based cohort study
|
Lee M.-H.; Yang H.-I.; Lu S.-N.; Jen C.-L.; Yeh S.-H.; Liu C.-J.; Chen P.-J.; You S.-L.; Wang L.-Y.; WEI J. CHEN; Chen C.-J. |
| 臺大學術典藏 |
2022-05-05T05:16:05Z |
Community and personal risk factors for hepatitis C virus infection: A survey of 23 820 residents in Taiwan in 1991-2
|
Lee M.-H.; Yang H.-I.; Jen C.-L.; Lu S.-N.; Yeh S.-H.; Liu C.-J.; You S.-L.; Sun C.-A.; Wang L.-Y.; WEI J. CHEN; Chen C.-J. |
| 臺大學術典藏 |
2022-05-05T05:15:59Z |
Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: A community-based long-term prospective study
|
Lee M.-H.; Yang H.-I.; Lu S.-N.; Jen C.-L.; You S.-L.; Wang L.-Y.; Wang C.-H.; WEI J. CHEN; Chen C.-J.; Hsieh C.Y.; Lee H.S.; Yang P.M.; Chen C.H.; Chen J.D.; Huang S.P.; Jan C.F.; Chen T.H.H.; Sun C.A.; Wu M.H.; Chen S.Y.; Chu K.E.; Ho S.C.; Lu T.G.; Wu W.P.; Ou T.Y.; Lin C.G.; Shih K.C.; Chung W.S.; Li C.; Chen C.C.; How W.C. |
| 臺大學術典藏 |
2022-04-28T12:31:37Z |
High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease
|
Lai T.-S.; Lee M.-H.; Yang H.-I.; You S.-L.; Lu S.-N.; Wang L.-Y.; Yuan Y.; L'Italien G.; KUO-LIONG CHIEN; Chen C.-J.; REVEAL-HCV Study Group |
| 臺大學術典藏 |
2022-04-28T12:31:36Z |
Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study
|
Lai T.-S.; Lee M.-H.; Yang H.-I.; You S.-L.; Lu S.-N.; Wang L.-Y.; Yuan Y.; L'Italien G.; KUO-LIONG CHIEN; Chen C.-J.; for the REVEAL-HCV Study Group |
| 臺大學術典藏 |
2022-04-21T06:51:50Z |
Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan
|
Chen, Tony Hsiu Hsi; Chen C.-J.; Yen M.-F.; Lu S.-N.; Sun C.-A.; Huang G.-T.; Yang P.-M.; Lee H.-S.; Duffy S.W. |
| 臺大學術典藏 |
2022-04-21T06:51:26Z |
Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: Geographic variations among 502 villages in southern Taiwan
|
Tsai M.-C.; Kee K.-M.; Chen Y.-D.; Lin L.-C.; Tsai L.-S.; Chen, Tony Hsiu Hsi; Lu S.-N. |
| 臺大學術典藏 |
2022-04-21T06:51:12Z |
Community-based mass ultrasonographic screening of hepatocellular carcinoma among thrombocytopenic adults
|
Lu S.-N.; Wang J.-H.; Chen P.-F.; Tung H.-D.; Tseng P.-L.; Hung C.-H.; Kee K.-M.; Chen C.-H.; Chang K.-C.; Lee C.-M.; Changchien C.-S.; Chen Y.-D.; Tsai L.-S.; Chen, Tony Hsiu Hsi |
| 臺大學術典藏 |
2022-04-21T06:51:08Z |
Identifying hepatitis C virus: endemic areas and estimating the viral antibody prevalence based on the prevalence of ALT elevation
|
Chiang J.-C.; Lin C.-Y.; Wang J.-H.; Kee K.-M.; Chen P.-F.; Chen Y.-D.; Tsai L.-S.; Chen, Tony Hsiu Hsi; Lu S.-N. |
| 臺大學術典藏 |
2022-04-21T06:50:53Z |
Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: A community-based long-term prospective study
|
Lee M.-H.; Yang H.-I.; Lu S.-N.; Jen C.-L.; You S.-L.; Wang L.-Y.; Wang C.-H.; Chen W.J.; Chen C.-J.; Hsieh C.Y.; Lee H.S.; Yang P.M.; Chen C.H.; Chen J.D.; Huang S.P.; Jan C.F.; Chen, Tony Hsiu Hsi; Sun C.A.; Wu M.H.; Chen S.Y.; Chu K.E.; Ho S.C.; Lu T.G.; Wu W.P.; Ou T.Y.; Lin C.G.; Shih K.C.; Chung W.S.; Li C.; Chen C.C.; How W.C. |
| 臺大學術典藏 |
2022-04-21T06:50:48Z |
Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy
|
Chang K.-C.; Wu Y.-Y.; Hung C.-H.; Lu S.-N.; Lee C.-M.; Chiu K.-W.; Tsai M.-C.; Tseng P.-L.; Huang C.-M.; Cho C.-L.; Chen, Tony Hsiu Hsi; Hu T.-H. |
| 臺大學術典藏 |
2022-04-21T06:50:39Z |
A polymorphism in interferon L3 Is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis c virus infection
|
Chang K.-C.; Tseng P.-L.; Wu Y.-Y.; Hung H.-C.; Huang C.-M.; Lu S.-N.; Wang J.-H.; Lee C.-M.; Chen C.-H.; Tsai M.-C.; Yen Y.-H.; Lin M.-T.; Wu C.-K.; Huang C.-C.; Chen, Tony Hsiu Hsi; Hu T.-H. |
| 臺大學術典藏 |
2022-04-20T07:19:36Z |
Hepatitis B e antigen and the risk of hepatocellular carcinoma
|
Yang H.-I.; Lu S.-N.; Liaw Y.-F.; You S.-L.; Sun C.-A.; Wang L.-Y.; CHUHSING KATE HSIAO; Chen P.-J.; Chen D.-S.; Chen C.-J. |
| 臺大學術典藏 |
2022-04-20T07:19:16Z |
Distinct seromarkers predict different milestones of chronic hepatitis B progression
|
Liu J.; Yang H.-I.; Lee M.-H.; Batrla-Utermann R.; Jen C.-L.; Lu S.-N.; Wang L.-Y.; You S.-L.; CHUHSING KATE HSIAO; Chen C.-J. |
| 臺大學術典藏 |
2022-04-20T07:19:16Z |
A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection
|
Liu J.; Lee M.-H.; Batrla-Utermann R.; Jen C.-L.; Iloeje U.H.; Lu S.-N.; Wang L.-Y.; You S.-L.; CHUHSING KATE HSIAO; Yang H.-I.; Chen C.-J. |
| 臺大學術典藏 |
2022-04-20T07:19:14Z |
Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma
|
Liu J.; Yang H.-I.; Lee M.-H.; Lu S.-N.; Jen C.-L.; Batrla-Utermann R.; Wang L.-Y.; You S.-L.; CHUHSING KATE HSIAO; Chen P.-J.; Chen C.-J. |
| 臺大學術典藏 |
2022-02-23T02:12:38Z |
Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: Analysis of 11 312 patients in Taiwan
|
CHIEN-HUNG CHEN; Su W.-W.; Yang S.-S.; Chang T.-T.; Cheng K.-S.; Lin H.H.; Wu S.-S.; Lee C.-M.; Changchien C.-S.; Chen C.-J.; Sheu J.-C.; Chen D.-S.; Lu S.-N. |
| 臺大學術典藏 |
2022-02-23T02:12:37Z |
Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan
|
Lu S.-N.; Su W.-W.; Yang S.-S.; Chang T.-T.; Cheng K.-S.; Wu J.-C.; Lin H.H.; Wu S.-S.; Lee C.-M.; Changchien C.-S.; Chen C.-J.; Sheu J.-C.; Chen D.-S.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:37Z |
Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients
|
CHIEN-HUNG CHEN; Chang T.-T.; Cheng K.-S.; Su W.-W.; Yang S.-S.; Lin H.H.; Wu S.-S.; Lee C.-M.; Changchien C.-S.; Chen C.-J.; Sheu J.-C.; Chen D.-S.; Lu S.-N. |
| 臺大學術典藏 |
2022-02-23T02:12:33Z |
Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: Identification of potential high HCV endemic areas
|
Su W.-W.; CHIEN-HUNG CHEN; Lin H.H.; Yang S.-S.; Chang T.-T.; Cheng K.-S.; Wu J.-C.; Wu S.-S.; Lee C.-M.; Changchien C.-S.; Chen C.-J.; Sheu J.-C.; Chen D.-S.; Lu S.-N. |
| 臺大學術典藏 |
2022-02-23T02:12:29Z |
Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: A community-based long-term prospective study
|
Lee M.-H.; Yang H.-I.; Lu S.-N.; Jen C.-L.; You S.-L.; Wang L.-Y.; Wang C.-H.; Chen W.J.; Chen C.-J.; Hsieh C.Y.; Lee H.S.; Yang P.M.; CHIEN-HUNG CHEN; Chen J.D.; Huang S.P.; Jan C.F.; Chen T.H.H.; Sun C.A.; Wu M.H.; Chen S.Y.; Chu K.E.; Ho S.C.; Lu T.G.; Wu W.P.; Ou T.Y.; Lin C.G.; Shih K.C.; Chung W.S.; Li C.; Chen C.C.; How W.C. |
| 臺大學術典藏 |
2022-02-23T02:12:24Z |
Current efficacy and prospectives of oral direct-acting antiviral drugs to treat chronic hepatitis c
|
Lo C.-C.; Chen M.-T.; Huang K.-C.; Lin C.-H.; Cheng H.-S.; Liao Y.-T.; Hung L.-W.; Lu S.-N.; CHIEN-HUNG CHEN |
